D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 27,101 295 World Ranking 12710 National Ranking 1169

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Statistics

Her scientific interests lie mostly in Acquired immunodeficiency syndrome, Cohort study, Internal medicine, Viral load and Immunology. Margaret T May interconnects Prospective cohort study, Interquartile range, Comorbidity and Confidence interval in the investigation of issues within Acquired immunodeficiency syndrome. Her Cohort study study combines topics in areas such as Mortality rate, Demography, Life expectancy, Antiretroviral therapy and Cohort.

Her study in Internal medicine is interdisciplinary in nature, drawing from both Sida and Surgery. The study incorporates disciplines such as Survival analysis and Pediatrics in addition to Viral load. The various areas that Margaret T May examines in her Hazard ratio study include Proportional hazards model and Risk factor.

Her most cited work include:

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (1341 citations)
  • Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies (1227 citations)
  • Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. (986 citations)

What are the main themes of her work throughout her whole career to date?

Margaret T May mostly deals with Internal medicine, Acquired immunodeficiency syndrome, Cohort, Cohort study and Demography. Her Internal medicine research includes themes of Surgery and Immunology. Her Acquired immunodeficiency syndrome research integrates issues from Mortality rate, Pediatrics, Viral load and Disease.

The concepts of her Cohort study are interwoven with issues in Body mass index, Young adult, Regimen, Pharmacotherapy and Physical therapy. Her research investigates the connection with Cohort study and areas like Risk factor which intersect with concerns in Framingham Risk Score. Her Demography study combines topics from a wide range of disciplines, such as Epidemiology, Incidence and Gerontology.

She most often published in these fields:

  • Internal medicine (33.33%)
  • Acquired immunodeficiency syndrome (23.33%)
  • Cohort (21.00%)

What were the highlights of her more recent work (between 2016-2021)?

  • Internal medicine (33.33%)
  • Cohort (21.00%)
  • Demography (18.33%)

In recent papers she was focusing on the following fields of study:

Her primary areas of investigation include Internal medicine, Cohort, Demography, Acquired immunodeficiency syndrome and Incidence. Her Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Oncology. Margaret T May combines subjects such as Parity, Cohort study and Antiretroviral therapy with her study of Cohort.

In her study, Young adult, Hiv infected patients and Pharmacy is inextricably linked to Viral load, which falls within the broad field of Cohort study. Her studies deal with areas such as Odds ratio and Logistic regression as well as Demography. Her Mortality rate research extends to the thematically linked field of Acquired immunodeficiency syndrome.

Between 2016 and 2021, her most popular works were:

  • Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies (399 citations)
  • First estimates of the global and regional incidence of neonatal herpes infection (82 citations)
  • Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study. (54 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Statistics

Margaret T May spends much of her time researching Internal medicine, Risk factor, Hepatitis C virus, Environmental health and Incidence. Her Cohort, Confidence interval, Hazard ratio and Severity of illness study in the realm of Internal medicine interacts with subjects such as Placebo. Her Hazard ratio research includes elements of Cohort study, Acquired immunodeficiency syndrome, Viral load and Comorbidity.

The Cohort study study combines topics in areas such as Levodopa, Prospective cohort study and Disease. Her work in Viral load addresses issues such as Proportional hazards model, which are connected to fields such as Young adult. Her research integrates issues of Odds ratio, Attributable risk and Hepatitis C in her study of Risk factor.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Matthias Egger;Margaret May;Geneviève Chene;Andrew N. Phillips.
The Lancet (2002)

2020 Citations

Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects

Yoav Ben-Shlomo;Melissa Spears;Chris Boustred;Margaret May.
Journal of the American College of Cardiology (2014)

1568 Citations

Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies

R Hogg;V Lima;J Sterne;S Grabar.
The Lancet (2008)

1543 Citations

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

P Braitstein;Mwg Brinkhof;F Dabis;M Schechter.
The Lancet (2006)

1313 Citations

Relation of Particle Dimension to Carcinogenicity in Amphibole Asbestoses and Other Fibrous Minerals

Mearl F. Stanton;Maxwell Layard;Andrew Tegeris;Eliza Miller.
Journal of the National Cancer Institute (1981)

1138 Citations

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

Julia Hippisley-Cox;Carol Coupland;Yana Vinogradova;John Robson.
BMJ (2007)

1124 Citations

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.

Jonathan A C Sterne;Margaret May;Dominique Costagliola;Frank de Wolf.
The Lancet (2009)

1014 Citations

Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

Adam Trickey;Margaret T May;Jorg-Janne Vehreschild;Niels Obel.
The Lancet HIV (2017)

823 Citations

Causes of death in HIV-1 infected patients treated with antiretroviral therapy 1996-2006: collaborative analysis of 13 HIV cohort studies

J Gill;Margaret T May;C Lewden;M Saag.
Clinical Infectious Diseases (2010)

718 Citations

Carcinogenicity of Fibrous Glass: Pleural Response in the Rat in Relation to Fiber Dimension

M F Stanton;M Laynard;A Tegeris;E Miller.
Journal of the National Cancer Institute (1977)

621 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Margaret T May

Matthias Egger

Matthias Egger

University of Bern

Publications: 153

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 145

Amy C. Justice

Amy C. Justice

Yale University

Publications: 135

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 118

Caroline Sabin

Caroline Sabin

University College London

Publications: 103

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 96

Peter Vickerman

Peter Vickerman

University of Bristol

Publications: 93

Dominique Costagliola

Dominique Costagliola

Sorbonne University

Publications: 85

Robin Wood

Robin Wood

University of Cape Town

Publications: 83

Richard D. Moore

Richard D. Moore

Johns Hopkins University

Publications: 82

Nathan Ford

Nathan Ford

World Health Organization

Publications: 80

Matthew Hickman

Matthew Hickman

University of Bristol

Publications: 78

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 76

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 71

François Dabis

François Dabis

University of Bordeaux

Publications: 69

Stephen D. Lawn

Stephen D. Lawn

London School of Hygiene & Tropical Medicine

Publications: 69

Trending Scientists

Charles C. Snow

Charles C. Snow

Pennsylvania State University

Romain Duval

Romain Duval

International Monetary Fund

Ian H. White

Ian H. White

University of Bath

Ross Dykstra Pursifull

Ross Dykstra Pursifull

Ford Motor Company (United States)

Francisco J. Maldonado-Hódar

Francisco J. Maldonado-Hódar

University of Granada

Jae Hyung Park

Jae Hyung Park

Sungkyunkwan University

Stephen Brimijoin

Stephen Brimijoin

Mayo Clinic

Robert A. Harley

Robert A. Harley

University of California, Berkeley

Perrine Plouin

Perrine Plouin

Necker-Enfants Malades Hospital

Frederic Geissmann

Frederic Geissmann

Memorial Sloan Kettering Cancer Center

Carolyn S.P. Lam

Carolyn S.P. Lam

National University of Singapore

Josep Font

Josep Font

University of Barcelona

Claudio Cobelli

Claudio Cobelli

University of Padua

Samir S. Taneja

Samir S. Taneja

New York University

Sarah Hawkes

Sarah Hawkes

University College London

Something went wrong. Please try again later.